- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04975659
Placebo Versus Nocebo: Effects on Pain and Anxiety During Local Anaesthetic Infiltration in Parturient Undergoing Elective Caesarean Delivery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We randomised participants into either the nocebo (N) or placebo (P) group. We obtained a baseline anxiety score (APAIS0) using the Amsterdam Preoperative Anxiety and Information Scale (APAIS) during the pre-anaesthesia visit. Following that, we informed subjects in the N group a negative suggestion, using the following script: "During the local anaesthetic injection, you are going to feel a sharp prick at your back; this is usually the most painful part of the procedure". On the other hand, we used a positive suggestion on the P group: "We will administer some local anaesthetic to numb your back; this will allow the procedure to be more comfortable and tolerable for you." We obtain a second anxiety score (APAIS1) in the operating theatre before the caesarean section. We carried out either spinal anaesthesia or continuous spinal epidural according to standard hospital protocol and indication. Before the LA skin infiltration, the anaesthetist repeats the same script to the subjects according to the prior randomisation. Five millilitres of lignocaine 2% is injected intradermally and subcutaneously by the anaesthetist into interspinous space in a single pass through a 22-gauge needle to create a skin wheal.
During the LA infiltration, only the attending anaesthetist performing the procedure gave participants verbal instructions; other personnel remained silent throughout. We recorded the presence of vocalisation of pain, withdrawal movement or facial grimacing. Immediately after the LA infiltration, a blinded and trained general anaesthetic nurse or personnel enters the operating theatre to assess the subjects' pain score using the numerical rating scale (NRS). After collection of the pain score, the anaesthetist performed the remaining anaesthetic procedure as per clinical routine.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kuala Lumpur
-
Cheras, Kuala Lumpur, Malaysia, 56000
- Hospital Canselor Tuanku Muhriz,
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- American Society of Anaesthesiology (ASA) II category parturient listed for elective caesarean delivery.
- Can understand intended verbal communication
Exclusion Criteria:
- receiving any form of analgesia within 6 hours before the study
- chronic pain,
- anxiety disorders
- allergy to Local Anaesthetic drugs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nocebo
We informed subjects in the N group a negative suggestion, using the following script: "During the local anaesthetic injection, you are going to feel a sharp prick at your back; this is usually the painful part of the procedure"
|
Positive suggestion and words is used on Placebo group Negative suggestion and words is used on Nocebo group
|
|
Placebo Comparator: Placebo
We informed subjects in the P group a positive suggestion, using the following script: "We will administer some local anaesthetic to numb your back; this will allow the procedure to be more comfortable and tolerable for you."
|
Positive suggestion and words is used on Placebo group Negative suggestion and words is used on Nocebo group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain score
Time Frame: Throughout study completion, average of 10 months
|
Pain score during local anaesthetic infiltration using Numerical Rating Scale (NRS) (range 0-10) where 0 is "no pain at all" and 10 is " worst pain ever felt"
|
Throughout study completion, average of 10 months
|
|
Baseline anxiety score
Time Frame: Through study completion, average of 10 months
|
Validated questionnare using the Amsterdam Preoperative Anxiety & Information Scale.
(APAIS) (Range 6-30).
Higher scores mean higher anxiety level
|
Through study completion, average of 10 months
|
|
Preoperative anxiety score
Time Frame: Through study completion, average of 10 months
|
Validated questionnare using the Amsterdam Preoperative Anxiety & Information Scale.
(Range 6-30).
Higher scores mean higher anxiety level
|
Through study completion, average of 10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Association of Education level on Pain and anxiety score
Time Frame: Through study completion, average of 10 months
|
Correlation between subjects education level on pain score (NRS) and anxiety score (APAIS)
|
Through study completion, average of 10 months
|
|
Association of past history of regional anesthesia on Pain and anxiety score
Time Frame: Through study completion, average of 10 months
|
Correlation between subjects previous experience of regional anesthesia on pain score (NRS) and anxiety score (APAIS)
|
Through study completion, average of 10 months
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Mohd Fahmi Z, Lai LL, Loh PS. Validation of the Malay version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Med J Malaysia. 2015 Aug;70(4):243-8.
- Varelmann D, Pancaro C, Cappiello EC, Camann WR. Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg. 2010 Mar 1;110(3):868-70. doi: 10.1213/ANE.0b013e3181cc5727. Epub 2009 Dec 30.
- Moerman N, van Dam FS, Muller MJ, Oosting H. The Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anesth Analg. 1996 Mar;82(3):445-51. doi: 10.1097/00000539-199603000-00002.
- Dutt-Gupta J, Bown T, Cyna AM. Effect of communication on pain during intravenous cannulation: a randomized controlled trial. Br J Anaesth. 2007 Dec;99(6):871-5. doi: 10.1093/bja/aem308. Epub 2007 Oct 30.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UKM PPl/111/8/JEP-2020-011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communication
-
Shanghai Zhongshan HospitalNot yet recruitingICU | Eye Tracking | Communication Barriers | Non-Verbal Communication
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; University of Bern; Fachhochschule NordwestschweizRecruitingCommunication Research | Communication, MultidisciplinarySwitzerland, Austria
-
University of Wisconsin, MadisonUniversity of South Florida; University of Pittsburgh; University of Oklahoma; Duke... and other collaboratorsEnrolling by invitationCommunication Research | Communication ProgramsUnited States
-
Florida State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Duquesne...CompletedSocial CommunicationUnited States
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruiting
-
Bozok UniversityNot yet recruiting
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
The University of Tennessee, KnoxvilleNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingTeacher Practice | Sign Language SkillsUnited States
-
Al-Hadba universityEnrolling by invitation
-
Johns Hopkins UniversityCompletedCommunication | Obstetric Complication | High Risk Pregnancy | Multidisciplinary CommunicationUnited States
Clinical Trials on Placebo and Nocebo effect
-
Université de SherbrookeRecruitingPain | Attention Deficit Disorder With Hyperactivity | Placebo Effect | Nocebo EffectCanada
-
Universidade Cidade de Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedNon-specific Chronic Low Back PainBrazil
-
Université de SherbrookeCompleted
-
Leiden University Medical CenterUniversiteit LeidenCompleted
-
John Paul II University of Applied Sciences in...CompletedCommunication | Activity, Motor | MusclePoland
-
HAN University of Applied SciencesCompletedChronic Pain | CommunicationNetherlands
-
HAN University of Applied SciencesCompleted
-
John Paul II University in Biała PodlaskaCompleted
-
Idorsia Pharmaceuticals Ltd.Completed
-
Quiropraxia y EquilibrioCompleted